About Verteporfin
            
            Class: | Photosensitizing agent, Antineoplastic  
Use: | Treatment of age-related macular degeneration (AMD) and other conditions involving choroidal neovascularization  
Adult dose: | 6 mg/m² body surface area administered as an intravenous infusion over 10 minutes, followed by laser treatment 15 minutes after infusion  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side effects: | Visual disturbances, headache, nausea, photos
         
        
            
                
                
                    
                        Drug Class
                    
                    Photosensitizing agent, Antineoplastic
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of age-related macular degeneration (AMD) and other conditions involving choroidal neovascularization
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novartis Pharma AG, SWITZERLAND
                    
                    
                    Package Size
                    Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 11770.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        6 mg/m² body surface area administered as an intravenous infusion over 10 minutes, followed by laser treatment 15 minutes after infusion
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Visual disturbances, headache, nausea, photosensitivity reactions, injection site reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to verteporfin or any component of the formulation; porphyria; concurrent use with other photosensitizing agents
         
        
        
            
                Important Warnings
            
            Risk of severe allergic reactions; patients should avoid direct sunlight and bright light for at least 48 hours post-infusion; monitor for signs of anaphylaxis during and after administration
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.